January 9, 2017
FOR MORE INFORMATION CONTACT: press@efferentlabs.com
Third Trademark Issued
(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product
Related Posts
Efferent Labs Issued 6th Patent
(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs Expands Development Collaboration with Gore
(CHARLESTON, S.C.) Mar 6, 2021/GlobeNewswire/ – Today, Efferent Labs announces an expanded development
About Us
Efferent Labs offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Let’s Socialize
Popular Post
Third Trademark Issued
April 1, 2022
Efferent Labs Issued 6th Patent
February 15, 2022